Safety, tolerability, and efficacy of a glucose-insulin-potassium- magnesium-carnitine solution in acute myocardial infarction

American Journal of Cardiology

Volumn 78, Issue 4, 1996, Pages 476-479

  Arsenian, Michael A ^a,b   New, Peter S ^a   Cafasso, Cynthia M ^a  

^a Division of Cardiology   (United States)

^b Cape Ann Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE; FUROSEMIDE; GLUCOSE; GLYCERYL TRINITRATE; HEPARIN; ISOPHANE INSULIN; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; ANTIDIABETIC AGENT; CALCIUM; CARDIOVASCULAR AGENT; DIURETIC AGENT; GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION; GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION; HYPERTONIC SOLUTION; INSULIN; MAGNESIUM; PHOSPHORUS; POTASSIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; DRUG TOLERANCE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; SAFETY;

AGED; BLOOD GLUCOSE; CALCIUM; CARDIOVASCULAR AGENTS; CARNITINE; DIURETICS; DRUG TOLERANCE; FEMALE; FUROSEMIDE; GLUCOSE; HUMANS; HYPERTONIC SOLUTIONS; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INSULIN; MAGNESIUM; MALE; MYOCARDIAL INFARCTION; PHOSPHORUS; POTASSIUM; SAFETY; THROMBOLYTIC THERAPY;

EID: 0030586844     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(97)00001-5     Document Type: Article

References (24)

1. 1. Sodi-Pallares D, Testelli MR, Fisleder BC, Bisteni A, Medrano GA, Friedland C, DeMicheli A. Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. Am J Cardiol 1962;9:166-167.
2. 2. Mittra B, Agra MB. Potassium, glucose and insulin in treatment of myocardial infarction. Lancet 1965;2:607-609.
3. 3. Pilcher J, Etishamudin M, Exon P, Moore J. Potassium, glucose, and insulin in myocardial infarction. Lancet 1967;1:1109.
4. 4. Medical Research Council Working Party. Potassium, glucose and insulin treatment for acute myocardial infarction. Lancet 1968;2:1355-1360.
5. 5. Rogers WJ, Stanley AW, Breinig JB, Prather JS, McDaniel HG, Moraski RE, Mantle JA, Russell RO, Rackley CE. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion. Am Heart J 1976;92:441-454.
6. 6. Rogers WJ, Segall PH, McDaniel HG, Mantle JA, Russell RO, Rackley CE. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Am J Cardiol 1979;43:801-809.
7. 7. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study); effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
8. 8. Apstein CS, Gravino FN, Haudenschild CC. Determinants of a protective effect of glucose and insulin on the ischemic myocardium: effects on contractile function, diastolic compliance, metabolism and ultrastructure during ischemia and reperfusion. Circ Res 1983;52:515-526.
9. 9. Maroko PR, Libby BA, Sobel BE, Bloor CM, Sybers HD, Shell WE, Covell JW, Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 1972;45:1160-1175.
10. 10. ISIS-4 Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
11. 11. Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990;66:271-274.
12. 12. Woods KL, Fletcher S, Roffe C. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-II). Lancet 1992;339:1553-1558.
13. 13. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995;75:321-323.
14. 14. Leor J, Kloner RA. An experimental model examining the role of magnesium in the therapy of acute myocardial infarction. Am J Cardiol 1995;75:1292-1293.
15. 15. Seelig MS, Elin RJ. Re-examination of magnesium infusions in myocardial infarction. Am J Cardiol 1995;76:172-173.
16. 16. Woods KL. Mega-trials and management of acute myocardial infarction. Lancet 1995;346:611-614.
17. 17. Antman EM. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol 1995;75:391-393.
18. 18. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia 1990;33:511-514.
19. 19. Broderick TL, Quinney A, Barker CC, Lopaschuk GD. Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation 1993;87:972-981.
20. 20. Risson P, Biasco G, DiBiase M, Boscia F, Rizzo U, Minafra F, Bortone A, Siliprandi N, Procopio A, Bagiella E, Corsi M. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Heart J 1989;10:502-508.
21. 21. Davini P, Bigalli A, Lamanna F, Boem A. Controlled study on L-carnitine therapeutic efficacy in post infarction. Drugs Exp Clin Res 1992;18:355-365.
22. 22. Iliceto S, Scrutinio D, Bruzzi P, D'Ambrosio G, Boni L, DiBiase M, Biasco G, Hugenholtzz P, Rizzon P. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-carnitine ecocardiografia digitalizata infarcto miocardico (CEDIM) trial. J Am Coll Cardiol 1995;26:380-387.
23. 23. Prather JW, Russell RO, Mantle JA, McDaniel HG, Rackley CE. Metabolic consequences of glucose-insulin-potassium infusion in treatment of acute myocardial infarction. Am J Cardiol 1976;38:95-99.
24. 24. Marwick TH, Woodhouse SP. Severe hypophosphataemia induced by glucose-insulin-potassium therapy. Int J Cardiol 1988;18:327-330.